Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Olli Polo
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
[[File:Olli Polo.png|200px|right|Source: investinme.org]] '''Olli Juhani Polo''', MD, PhD, is a Finnish pulmonologist, sleep specialist, physiology physician and CFS/ME expert working in Stockholm, [[Sweden]].<ref name="researchgate" /><ref name="EUROMENE2021" /> He was formerly a professor of pulmonology at Tampere university,<ref name="researchgate">{{Cite web|url=https://www.researchgate.net/profile/Olli-Polo-2 | title = Olli J. Polo - profile | last = | first = | authorlink = | date = |website=Researchgate|archive-url=|archive-date=|url-status=|access-date=}}</ref> but lost the professorship in 2014 as a result of official complaints made against him by insurance doctors.{{citation needed | date = 2022}} Dr Polo had his own clinic, Unesta, where he mostly treated and studied CFS/ME, [[RLS]] and [[sleep apnea]]. Since 2019 he has been working as a clinician at [[Bragee ME center Stockholm]].<ref name="EUROMENE2021">{{Cite journal | title = European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe | date = 2021-05-19|url=https://www.mdpi.com/1648-9144/57/5/510|journal=Medicina|volume=57|issue=5 | pages = 510 | last = Nacul | first = Luis | last2 = Authier | first2 = François Jérôme | last3 = Scheibenbogen | first3 = Carmen | last4 = Lorusso | first4 = Lorenzo | last5 = Helland | first5 = Ingrid Bergliot | last6 = Martin | first6 = Jose Alegre | last7 = Sirbu | first7 = Carmen Adella | last8 = Mengshoel | first8 = Anne Marit | last9 = Polo | first9 = Olli | last10 = Behrends | first10 = Uta | last11 = Nielsen | first11 = Henrik|language=en|doi=10.3390/medicina57050510|pmc=PMC8161074|pmid=34069603|issn=1648-9144}}</ref> He has also treated [[multiple chemical sensitivity]] and [[mold illness]]. Polo has been treating and studying CFS/ME since 2007, but he lost his license to practice medicine on the private sector in 2017.<ref name="Valvira2017">{{Cite web|url=http://www.valvira.fi/-/laakari-olli-polon-ammattioikeuden-rajoittamista-koskeva-paatos-on-edelleen-voimassa | title = Lääkäri Olli Polon ammattioikeuden rajoittamista koskeva päätös on edelleen voimassa | last = | first = | authorlink = | date = |website=Valvira|language=fi|archive-url=|archive-date=|url-status=|access-date=2022-02-21}}</ref> This decision remains in effect even though just days later a Finnish court decided that the 2014 complaints, on which the legal action was based, were unwarranted in the light of scientific evidence. Polo is still allowed to practice pulmonary medicine at the Tampere University hospital.{{citation needed | date = 2022}} Olli Polo is a member of the [[EUROMENE]] group of ME/CFS specialists and has published over 100 papers in prominent journals about sleep disorders, particularly [[restless leg syndrome]] (RLS), [[sleep apnea]] and the effect of [[menopause]] on sleep. He has been a speaker at the 2016 [[Invest in ME International ME Conference]] in London and many smaller CFS/ME conferences and events. ==Theories == Polo's ideas of the causal mechanisms of CFS/ME are focused on the [[sympathetic nervous system]], [[circadian rhythm]] and tissue [[hypoxia]]. He believes [[Ehlers-Danlos syndrome]] or a similar type of collagen abnormality underlies virtually every case of CFS/ME. He has documented this in hundreds of patients and the evidence has been the subject of many of his conference speeches.{{citation needed | date = 2022}} ==Treatments == Polo has developed several experimental medical therapies, as well as utilizing more common treatments like [[Low dose naltrexone|LDN]], [[supplemental oxygen]], [[saline]], [[vitamin B12]], [[rotigotine]] and [[pramipexole]]. He believes most psychiatric drugs, sleeping pills, and [[Lyrica]] (pregabelin) are harmful in CFS/ME patients.{{citation needed | date = 2022}} Polo has been a vocal advocate for CFS/ME, [[multiple chemical sensitivity]] and [[mold illness]] in the Finnish media and has been interviewed in TV, radio, online documentaries and many newspaper and magazine articles. This has not always been positively received by his colleagues.{{citation needed | date = 2022}} ===LDN research == For years Polo applied for permission to run clinical trials on [[Low dose naltrexone|LDN]] and his experimental treatments, but his applications was always turned down. The Finnish regulatory agencies are of the opinion that CFS/ME is such a mild illness that virtually any potential side effect, no matter how minor, would be unacceptable.{{citation needed | date = 2022}} In 2017 Polo finally got the permission to run an LDN study. It had just completed enrollment, when he was barred from continuing it due to losing his right to private medical practice. He has, however, compiled a retrospective paper on using LDN in hundreds of his CFS/ME patients.<ref name="Polo2019" /> == Reseach studies == * 2021, European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe<ref name="EUROMENE2021" /> - [https://www.mdpi.com/1648-9144/57/5/510/htm (Full text)] * 2019, Dampness and mold hypersensitivity syndrome and vaccination as risk factors for chronic fatigue syndrome<ref>{{Cite journal | last = Tuuminen | first = Tamara | authorlink = Tamara Tuuminen | last2 = Jääskeläinen | first2 = Tiina | authorlink2 = Tiina Jääskeläinen | last3 = Vaali | first3 = Kirsi | authorlink3 = Kirsi Vaali | last4 = Polo | first4 = Olli | authorlink4 = Olli Polo | date = Nov 2018 | title = Dampness and mold hypersensitivity syndrome and vaccination as risk factors for chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S1568997218302660|journal=Autoimmunity Reviews|volume=|issue=|pages=|doi=10.1016/j.autrev.2018.08.004|issn=1568-9972|quote=|via=}}</ref> - [https://www.sciencedirect.com/science/article/pii/S1568997218302660?via%3Dihub (Full text)] * 2019, Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)<ref name="Polo2019">{{Cite journal | last = Polo | first = Olli | authorlink = Olli Polo | last2 = Pesonen | first2 = Pia | authorlink2 = | last3 = Tuominen | first3 = Essi | author-link3 = | date = 2019-11-19 | title = Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)|url=https://www.tandfonline.com/doi/full/10.1080/21641846.2019.1692770|journal = Fatigue: Biomedicine, Health & Behavior |language=en|volume=|issue=|pages=1–11|doi=10.1080/21641846.2019.1692770|issn=2164-1846|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.tandfonline.com/doi/abs/10.1080/21641846.2019.1692770?journalCode=rftg20 (Abstract)] ==Talks and interviews== *2016, Speaker at the 11th Invest in ME International ME Conference on "Clinical Diagnosis of Myalgic Encephalomyelitis"<ref name="IIMER2016">{{Cite web|url=http://www.investinme.org/Documents/IIMEC11/IIMEC11%20Conference%20Report.pdf | title = 11th Invest in ME – Research International ME Conference 2016 | last = Vallings | first = Rosamund | authorlink=Rosamund Vallings | date = 2016 | website = Invest in ME Research|archive-url=|archive-date=|url-status=|access-date=2019-12-04}}</ref> - [http://www.investinme.org/IIMEC11.shtml#dvd DVD available] *2017, Speaker at the Care4ME conference in Brussels on sleep and dysautonomia in ME. - [https://www.youtube.com/watch?v=3v-2c2meSxw YouTube video] ==Learn more== * [http://symposium2014.semmelweis.hu/images/speakers/Polo_Olli.pdf Curriculum Vitae] ==See also== *[[Bragee ME center Stockholm]] *[[Invest in ME International ME Conference]] *[[EUROMENE]] *[[Finland]] ==References== {{Reflist}} [[Category:Clinicians]] [[Category:Finnish clinicians]] [[Category:Researchers]] [[Category:Finland researchers]] [[Category:Swedish clinicians]] [[Category:Sweden researchers]]
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Templates used on this page:
Template:Category handler
(
edit
)
Template:Citation needed
(
edit
)
Template:Cite journal
(
edit
)
Template:Cite web
(
edit
)
Template:Colon
(
edit
)
Template:Digits
(
edit
)
Template:Fix
(
edit
)
Template:Fix/category
(
view source
) (protected)
Template:GetFallback
(
edit
)
Template:LangSwitch
(
edit
)
Template:Last word
(
edit
)
Template:Main other
(
edit
)
Template:Reflist
(
edit
)
Template:Str len
(
edit
)
Template:Uselang
(
edit
)
Template:Year
(
edit
)
Module:Arguments
(
edit
)
Module:Category handler
(
edit
)
Module:Category handler/blacklist
(
edit
)
Module:Category handler/config
(
edit
)
Module:Category handler/data
(
edit
)
Module:Category handler/shared
(
edit
)
Module:Check for unknown parameters
(
edit
)
Module:Citation/CS1
(
edit
)
Module:Citation/CS1/COinS
(
edit
)
Module:Citation/CS1/Configuration
(
edit
)
Module:Citation/CS1/Date validation
(
edit
)
Module:Citation/CS1/Identifiers
(
edit
)
Module:Citation/CS1/Utilities
(
edit
)
Module:Citation/CS1/Whitelist
(
edit
)
Module:Namespace detect/config
(
edit
)
Module:Namespace detect/data
(
edit
)
Module:No globals
(
edit
)
Module:String
(
edit
)
Module:Unsubst
(
edit
)
Module:Yesno
(
edit
)
This page is a member of 2 hidden categories:
Category:All articles with unsourced statements
Category:Articles with unsourced statements from 2022
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs